Navigation Links
Cost-effective antibiotics for sinusitis treatment

here is little benefit in replacing older and cheaper antibiotics by the latest and most expensive drugs when treating acute, uncomplicated sinusitis, according to US researchers. Researchers at the Washington University School of Medicine set out to determine whether the symptoms could be treated with older and less expensive (first-line) antibiotics or newer and more expensive (second-line) antibiotics. //

Dr Jay Piccirillo and his team examined data from 29,102 adults with a diagnosis of acute sinusitis receiving initial antibiotic treatment. The antibiotic treatment received was divided into first-line therapy and second-line therapy. First-line antibiotics include amoxycillin, trimethoprim/sulphamethoxazole or erythromycin.

Results showed that the majority of patients received one of the first-line antibiotics, with amoxycillin being the most frequently prescribed. Of the 17,329 patients who received first-line treatment the success rate was 90.1 per cent and for the 11,773 patients receiving second-line treatment the success rate was 90.8 per cent.

Although the success rate in both types of treatment was similar, there was a difference in cost of $66.19 – indicating that the cost of care was significantly higher for patients treated with a second-line antibiotic.


'"/>




Page: 1

Related medicine news :

1. Cost-effective Meningitis Vaccine To Be Launched In Africa
2. Lowering Contrast Material Injection in Aged Patients is Cost-effective and can Offset Risks
3. Prevention (Of AIDS) By Circumcision More Cost-effective Than Cure
4. One-time Melanoma Screening Appears to Be Cost-effective for Elderly People
5. Need for Cost-effective Hearing Implants
6. Gene clue to antibiotics
7. Excessive use of antibiotics for sore throat
8. Treatment of antibiotics ineffectual in bronchitis
9. Use of antibiotics in farms may increase ‘super bugs
10. Frequent use of antibiotics raises the risk of carrying resistant infections
11. Intestinal Disorders Caused By Overuse of antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... May 25, 2016 , ... Dr. Travis Schwarz is an experienced dentist ... Road, O’Fallon, MO 63366. He serves patients of all ages with a full menu ... Schwarz’s success is reflected in the superior patient reviews that he has consistently earned ...
(Date:5/25/2016)... ... May 25, 2016 , ... DKT International, one of the ... is pleased to release their 2015 global impact data. In 2015, DKT served ... maternal deaths and 3.8 million unsafe abortions across 21 countries worldwide. , ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... its annual Medical and Prescription Drug survey , an employee benefits ... survey, which was conducted in December 2015, indicates that employers are turning to ...
(Date:5/25/2016)... CA (PRWEB) , ... May 25, 2016 , ... "FCPX ... the quality of your footage," said Christina Austin - CEO of Pixel Film Studios. ... editors can quickly and easily add stylish color grades to their footage. A LUT ...
(Date:5/25/2016)... Atlanta GA (PRWEB) , ... May 25, 2016 ... ... workplace solutions builder, has announced that it will join America's leading engineers at ... will be held at the Georgia World Congress Center. , Engineers, speakers ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
(Date:5/22/2016)... -- DS Biopharma (DS) today announced ... DS102 in chronic obstructive pulmonary disease (COPD) patients ... Recent DS preclinical data suggests that ... has bronchodilatory, anti-inflammatory and anti-fibrotic properties in the ... publish further detail on these findings later in ...
(Date:5/20/2016)... 2016 The Biotech arena remains ... the industry is not far from recovering. There are ... the following four equities: Anacor Pharmaceuticals Inc. (NASDAQ: ... ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... Sign up for your free trading alerts on these ...
Breaking Medicine Technology: